ABVC BioPharma, Inc. Increase (Decrease) in Contract with Customer, Liability
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Contract with Customer, Liability of -$68.52 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-03-03
- ABVC BioPharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was -$1.00.
- ABVC BioPharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was $0.00.
- ABVC BioPharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$68.52K, a 4342.41% decline from fiscal 2024.
- ABVC BioPharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was $1.61K, a 97.64% decline from fiscal 2023.
- ABVC BioPharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $68.52K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$68.52K 10-K · filed 2026-03-03 | |||
| 2024-12-31 | $1.61K 10-K · filed 2026-03-03 | |||
| 2023-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$1.00 derived: sum of 2 quarters · filed 2025-04-15 | $68.52K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $68.52K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $68.52K 10-Q · filed 2024-08-14 |